- Profile
- prev
- next
General
-
Headquarters
Palo Alto, California 94304, United States
-
Founders & Team
Amy Wagers, Rick Lee, Dr. Sebastian Eriksson Giwa, Mark Allen
-
Year Founded
2017
-
Number of employees
50
-
Company type
Private company
-
Funding stage
Seed
-
Total funding ($M)
24.3
-
Investors
Bold Capital Partners, For Good Ventures, Kizoo Ventures, Lauder Partners, Longevity Fund, Prime Movers Lab, SavEarth Fund, WTI
Technical Details
-
Aging Target
Altered intercellular communication, Cell Loss
-
Product modality
proteins
About
Elevian develops regenerative medicines that target root-cause aging mechanisms. We are a spin out from Harvard, led by a team of serial entrepreneurs and Harvard scientists.
Elevian’s founders have identified blood factors that regulate aging and stimulate the body’s natural repair and regeneration mechanisms. One well published example, GDF11, reduces age-related cardiac hypertrophy, accelerates skeletal muscle repair, and improves cognitive function in aged mammals. We are developing biotherapeutics that regulate these blood factors.